MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock
$4,22
Fiyat · May 20, 2026
Temel veriler itibarıyla May 8, 2026
52 Haftlık Aralık
$2–$5
74% of range
Analist Derecelendirmesi
BUY
16 analysts
Fiyat Hedefi
$6
+35% upside
P/E (TTM)
-3.6
ROE
-48.6%
Net Kâr Marjı
-70.4%
MRVI Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$4.21
Piyasa Değeri
—
P/E (TTM)
-3.6
EPS (TTM)
$-0.90
Gelir (TTM)
$186M
Temettü Verimi
—
ROE
-48.6%
D/E Borç/Özsermaye
1.4
52 Haftlık Aralık
$2 – $5
MRVI Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$186M
2019-12-31
→
2025-12-31
Hisse Başına Kâr
$-0.90
2019-12-31
→
2025-12-31
Serbest Nakit Akışı
$-71M
2021-12-31
→
2025-12-31
Marjlar
-70.4%
2025-12-31
→
2025-12-31
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
MRVI
Akran Ortalaması
P/E (TTM)
-3.6
28.9
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
MRVI
Akran Ortalaması
Gross Margin (Brüt Kar Marjı)
18.3%
46.0%
Operating Margin (Faaliyet Kâr Marjı)
-115.9%
—
Net Profit Margin (Net Kâr Marjı)
-70.4%
-8.1%
ROA
-14.7%
-3.6%
ROE
-48.6%
-4.5%
ROIC
-41.9%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
MRVI
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
1.4
36.5
Current Ratio (Cari Oran)
6.6
3.9
Quick Ratio (Cari Oran)
5.4
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
MRVI
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
-28.3%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
-40.5%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
-8.2%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
MRVI
Akran Ortalaması
MRVI Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
16 analist
- Güçlü Al 4 25,0%
- Al 6 37,5%
- Tut 6 37,5%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
5 analist · 2026-05-16
Medyan
$6.00
Ortalama
$5.70
← Tüm hedeflerin altında
$4.21
Düşük
$5.00
Yüksek
$6.00
Medyan hedef
$6.00
+42,3%
Ortalama hedef
$5.70
+35,2%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.02%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $0.01 | $-0.05 | 0.06% |
| 31 Aralık 2025 | $-0.04 | $-0.07 | 0.03% |
| 30 Eylül 2025 | $-0.08 | $-0.08 | 0.00% |
| 30 Haziran 2025 | $-0.08 | $-0.07 | -0.01% |
| 31 Mart 2025 | $-0.08 | $-0.07 | -0.01% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| MRVI | — | -3.6 | -28.3% | -70.4% | -48.6% | 18.3% |
| ADPT | $2.50B | -41.6 | 54.8% | -21.5% | -28.2% | — |
| ALMR | — | — | — | — | — | — |
| FTRE | $1.61B | -1.6 | 1.0% | -36.2% | -171.1% | — |
| BLFS | — | -241.8 | 28.9% | — | — | — |
| AZTA | $1.32B | -23.5 | 3.5% | -9.4% | -3.3% | 45.5% |
| PSNL | $816M | -8.7 | -17.7% | -116.7% | -36.0% | — |
| CYRX | $479M | 6.9 | 12.4% | 44.4% | 15.3% | 47.1% |
| MLAB | $647M | -329.6 | 11.5% | -0.82% | -1.2% | 62.6% |
| CTKB | $649M | 505.0 | 0.52% | -33.0% | -18.5% | 51.8% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 18
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $186M | $259M | $289M | $883M | $799M | $284M | $143M | |
| Cost of Revenue | $152M | $151M | $149M | $169M | $141M | $80M | $67M | |
| Gross Profit | $34M | $108M | $140M | · | · | · | · | |
| R&D Expense | $17M | $19M | $17M | $18M | $15M | $9M | $4M | |
| SG&A Expense | $145M | $162M | $151M | $129M | $100M | $94M | $48M | |
| Operating Expenses | $249M | $344M | $172M | $309M | $245M | $164M | $119M | |
| Operating Income | $-215M | $-236M | $-32M | $574M | $555M | $120M | $24M | |
| Interest Expense | · | · | $46M | $20M | $30M | $31M | $30M | |
| Interest Income | $11M | $27M | $28M | $2M | $0 | $0 | · | |
| Other Non-op | $-4M | $-2M | $-1M | $-358.0K | $279.0K | $126.0K | $118.0K | |
| Pretax Income | $-235M | $-261M | $618M | $551M | $531M | $82M | $-6M | |
| Income Tax | $-4M | $-2M | $756M | $61M | $62M | $3M | $-652.0K | |
| Net Income | $-131M | $-145M | $-119M | $220M | $182M | $89M | $-4M | |
| EPS (Basic) | $-0.90 | $-1.05 | $-0.90 | $1.67 | $1.59 | $7.43 | $-0.03 | |
| EPS (Diluted) | $-0.90 | $-1.05 | $-0.90 | $1.67 | $1.56 | $2.36 | $-0.03 | |
| Shares (Basic) | 144,360,000 | 137,906,000 | 131,919,000 | 131,545,000 | 114,791,000 | 10,351,000 | 253,917,000 | |
| Shares (Diluted) | 144,360,000 | 137,906,000 | 131,919,000 | 255,323,000 | 257,803,000 | 28,908,000 | 253,917,000 | |
| EBITDA | $-215M | $-236M | $-32M | $574M | $555M | · | · |
Bilanço 25
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $217M | $322M | $575M | $632M | $551M | $236M | · | |
| Receivables | $25M | $39M | $55M | $139M | $118M | $51M | · | |
| Inventory | $40M | $50M | $51M | $43M | $52M | $33M | · | |
| Prepaid Expense | $13M | $18M | $19M | $26M | $20M | $11M | · | |
| Current Assets | $296M | $429M | $700M | $848M | $740M | $332M | · | |
| PP&E (Net) | $151M | $164M | $163M | $53M | $46M | $101M | · | |
| Accum. Depreciation | $68M | $53M | $32M | $20M | $13M | $11M | · | |
| Goodwill | $129M | $160M | $326M | $284M | $153M | $224M | · | |
| Intangibles | $152M | $195M | $221M | $217M | $118M | $178M | · | |
| Other Non-current Assets | $42M | $60M | $78M | $116M | $53M | $4M | · | |
| Total Assets | $771M | $1.01B | $1.49B | $2.28B | $1.92B | $1.27B | · | |
| Accounts Payable | $3M | $12M | · | $6M | $8M | $8M | · | |
| Accrued Liabilities | $37M | $40M | $60M | $53M | $35M | $39M | · | |
| Current Liabilities | $45M | $57M | $87M | $110M | $94M | $131M | · | |
| Capital Leases | $34M | $41M | $48M | $52M | $41M | $56M | · | |
| Deferred Tax | · | $11.0K | · | $0 | $0 | $9M | · | |
| Other Non-current Liabilities | $36M | $52M | $59M | $69M | $41M | $2M | · | |
| Total Liabilities | $398M | $431M | $698M | $1.38B | $1.37B | $1.12B | · | |
| Long-term Debt | $292M | $296M | $524M | $527M | $531M | $535M | · | |
| Total Debt | $292M | $296M | $524M | $527M | $531M | · | · | |
| Paid-in Capital | $199M | $182M | $129M | $138M | $128M | $85M | · | |
| Retained Earnings | $10M | $141M | $286M | $405M | $185M | $854.0K | · | |
| AOCI | $524.0K | $0 | · | · | $0 | $-44.0K | · | |
| Stockholders' Equity | $212M | $325M | $417M | $545M | $315M | $89M | · | |
| Liabilities + Equity | $771M | $1.01B | $1.49B | $2.28B | $1.92B | $1.27B | · |
Nakit Akışı 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $30M | $49M | $35M | $19M | $10M | $25M | $2M | |
| Deferred Tax | $-20.0K | $11.0K | $755M | $42M | $47M | $-5M | $-1M | |
| Amort. of Intangibles | $28M | $28M | $27M | $24M | $18M | $20M | $20M | |
| Restructuring | $18M | $-1M | $6M | $0 | $0 | · | · | |
| Operating Cash Flow | $-58M | $7M | $126M | $536M | $369M | $152M | $24M | |
| CapEx | $13M | $30M | $66M | $17M | $15M | $25M | $17M | |
| Investing Cash Flow | $-31M | $-24M | $-122M | $-268M | $106M | $6M | $-17M | |
| Debt Issued | · | $953.0K | $0 | $8M | $0 | $609M | $0 | |
| Net Debt Issued | $-5M | $-233M | $-5M | $-5M | $-6M | · | · | |
| Stock Repurchased | · | · | · | $0 | $0 | $34M | $0 | |
| Net Stock Activity | · | · | · | $0 | $0 | · | · | |
| Financing Cash Flow | $-16M | $-236M | $-61M | $-187M | $-159M | $53M | $-4M | |
| Net Change in Cash | $-106M | $-253M | $-57M | $81M | $315M | $211M | $3M | |
| Taxes Paid | $-555.0K | $670.0K | $-3M | $23M | $22M | · | · | |
| Free Cash Flow | $-71M | $-22M | $61M | $519M | $354M | · | · | |
| Levered FCF | · | · | $71M | $501M | $327M | · | · |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 18.3% | · | · | · | · | · | · | |
| Operating Margin | -115.9% | -90.9% | -10.9% | 65.0% | 69.4% | · | · | |
| Net Margin | -70.4% | -55.9% | -41.2% | 24.9% | 22.8% | · | · | |
| Pretax Margin | -126.5% | -100.9% | 213.8% | 62.5% | 66.4% | · | · | |
| EBITDA Margin | -115.9% | -90.9% | -10.9% | 65.0% | 69.4% | · | · | |
| ROA | -14.7% | -12.7% | -6.3% | 10.5% | 11.4% | · | · | |
| ROE | -48.6% | -43.2% | -24.8% | 51.2% | 90.1% | · | · | |
| ROIC | -41.9% | -37.7% | 0.75% | 47.6% | 58.0% | · | · |
Likidite ve Solventlik 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.6 | 7.5 | 8.0 | 7.7 | 7.9 | · | · | |
| Quick Ratio | 5.4 | 6.3 | 7.2 | 7.0 | 7.1 | · | · | |
| Debt / Equity | 1.4 | 0.9 | 1.3 | 1.0 | 1.7 | · | · | |
| LT Debt / Equity | 1.3 | 0.9 | 1.2 | 1.0 | 1.7 | · | · | |
| Interest Coverage | · | · | -0.7 | 28.1 | 18.3 | · | · |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | 0.2 | 0.4 | 0.5 | · | · | |
| Inventory Turnover | 3.4 | 3.0 | 3.1 | 3.6 | 3.3 | · | · | |
| Receivables Turnover | 5.8 | 7.7 | 3.0 | 6.9 | 9.5 | · | · |
Büyüme Oranları 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -28.3% | -10.3% | -67.3% | 10.5% | 181.3% | · | · | |
| Revenue CAGR 3Y | -40.5% | -31.3% | 0.57% | · | · | · | · | |
| Revenue CAGR 5Y | -8.2% | · | · | · | · | · | · | |
| EPS YoY | · | · | · | 7.0% | -33.9% | · | · | |
| Net Income YoY | · | · | · | 21.0% | 104.6% | · | · |
Değerleme (TTM) 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $186M | $259M | $289M | $883M | $799M | $284M | · | |
| Net Income TTM | $-131M | $-145M | $-119M | $220M | $182M | $89M | · | |
| P/E | -3.6 | -5.2 | -7.3 | 8.6 | 26.9 | 11.9 | · | |
| Earnings Yield | -27.7% | -19.3% | -13.7% | 11.7% | 3.7% | 8.4% | · |
Gelir Tablosu 18
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $66M | $50M | $42M | $47M | $47M | $57M | $69M | $69M | $64M | $74M | $67M | $69M | $79M | $205M | $191M | $243M | |
| Cost of Revenue | $32M | $37M | $36M | $40M | $39M | $37M | $37M | $39M | $38M | $35M | $37M | $43M | $34M | $53M | $38M | $37M | |
| Gross Profit | $34M | $13M | $6M | · | $8M | $19M | $32M | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $4M | $5M | $5M | $4M | |
| SG&A Expense | $29M | $32M | $35M | $39M | $40M | $41M | $39M | $41M | $41M | $38M | $39M | $35M | $39M | $37M | $31M | $28M | |
| Operating Expenses | $36M | $-7M | $47M | $114M | $57M | $-20M | $198M | $83M | $83M | $-67M | $82M | $81M | $76M | $95M | $74M | $62M | |
| Operating Income | $-2M | $-59M | $-41M | $-66M | $-49M | $-38M | $-166M | $-13M | $-19M | $-7M | $-15M | $-12M | $3M | $109M | $117M | $181M | |
| Interest Expense | · | · | · | · | · | · | $14M | $12M | $11M | · | $12M | $7M | $12M | · | $3M | $4M | |
| Interest Income | $2M | $2M | $3M | $3M | $3M | $6M | $7M | $7M | $7M | $7M | $7M | $7M | $6M | $2M | $0 | $0 | |
| Other Non-op | $-494.0K | $-43.0K | $-71.0K | $-4M | $24.0K | $43.0K | $72.0K | $-3M | $106.0K | $49.0K | $66.0K | $-2M | $168.0K | $914.0K | $-4.0K | $-1M | |
| Pretax Income | $-7M | $-63M | $-45M | $-74M | $-53M | $-46M | $-172M | $-21M | $-22M | $656M | $-21M | $-13M | $-5M | $96M | $114M | $175M | |
| Income Tax | $-151.0K | $6.0K | $-92.0K | $-4M | $162.0K | $-7.0K | $311.0K | $-2M | $271.0K | $766M | $-5M | $-1M | $-3M | $8M | $14M | $18M | |
| Net Income | $-4M | $-36M | $-26M | $-40M | $-30M | $-26M | $-97M | $-10M | $-12M | $-106M | $-6M | $-7M | $-67.0K | $38M | $44M | $71M | |
| EPS (Basic) | $-0.02 | $-0.24 | $-0.18 | $-0.27 | $-0.21 | $-0.21 | $-0.68 | $-0.07 | $-0.09 | $-0.80 | $-0.05 | $-0.05 | $0.00 | $0.28 | $0.34 | $0.54 | |
| EPS (Diluted) | $-0.02 | $-0.24 | $-0.18 | $-0.27 | $-0.21 | $-0.21 | $-0.68 | $-0.07 | $-0.09 | $-0.80 | $-0.05 | $-0.05 | $0.00 | $0.30 | $0.34 | $0.53 | |
| Shares (Basic) | 146,426,000 | -287,984,000 | 144,683,000 | 144,236,000 | 143,425,000 | -271,824,000 | 141,555,000 | 135,842,000 | 132,333,000 | -263,614,000 | 131,930,000 | 131,864,000 | 131,739,000 | -263,008,000 | 131,540,000 | 131,524,000 | |
| Shares (Diluted) | 146,426,000 | -287,984,000 | 144,683,000 | 144,236,000 | 143,425,000 | -271,824,000 | 141,555,000 | 135,842,000 | 132,333,000 | -263,614,000 | 131,930,000 | 131,864,000 | 131,739,000 | -386,976,000 | 131,651,000 | 255,361,000 | |
| EBITDA | $-2M | · | $-41M | $-66M | $-49M | · | $-169M | $-10M | $-19M | · | $-15M | $-12M | $3M | · | $117M | $181M |
Bilanço 25
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $166M | $217M | $244M | $270M | $285M | $322M | $578M | $573M | $562M | · | $580M | $580M | $628M | · | $617M | $551M | |
| Receivables | $33M | $25M | $23M | $28M | $28M | $39M | $29M | $39M | $37M | · | $46M | $49M | $56M | · | $114M | $120M | |
| Inventory | $40M | $40M | $45M | $47M | $50M | $50M | $50M | $49M | $50M | · | $49M | $47M | $55M | · | $62M | $60M | |
| Prepaid Expense | $12M | $13M | $14M | $15M | $13M | $18M | $22M | $17M | $17M | · | $23M | $23M | $26M | · | $23M | $20M | |
| Current Assets | $252M | $296M | $326M | $360M | $376M | $429M | $679M | $685M | $668M | · | $701M | $699M | $766M | · | $836M | $759M | |
| PP&E (Net) | · | $151M | · | · | · | $164M | · | · | · | · | · | · | · | · | $48M | $47M | |
| Accum. Depreciation | · | $68M | · | · | · | $53M | · | · | · | · | · | · | · | · | · | · | |
| Goodwill | $129M | $129M | $129M | $129M | $160M | $160M | $172M | $326M | $326M | · | $326M | $326M | $327M | · | $284M | $284M | |
| Intangibles | $145M | $152M | $186M | $193M | $200M | $195M | $202M | $207M | $214M | · | $228M | $235M | $242M | · | $223M | $229M | |
| Other Non-current Assets | $40M | $42M | $49M | $52M | $58M | $60M | $61M | $63M | $75M | · | $86M | $93M | $127M | · | $87M | $72M | |
| Total Assets | $713M | $771M | $849M | $897M | $960M | $1.01B | $1.28B | $1.45B | $1.44B | · | $2.27B | $2.26B | $2.32B | · | $2.25B | $2.17B | |
| Accounts Payable | $9M | $3M | $8M | $12M | $10M | $12M | · | · | · | · | · | · | $5M | · | $9M | $23M | |
| Accrued Liabilities | $29M | $37M | $48M | $50M | $45M | $40M | $38M | $41M | $35M | · | $56M | $50M | $70M | · | $60M | $44M | |
| Current Liabilities | $43M | $45M | $62M | $70M | $63M | $57M | $63M | $69M | $59M | · | $78M | $75M | $125M | · | $116M | $113M | |
| Capital Leases | · | $34M | $36M | $38M | · | $41M | · | · | · | · | $50M | $52M | $54M | · | $44M | · | |
| Deferred Tax | · | · | · | $2M | $2M | · | · | · | · | · | $7M | $9M | $9M | · | · | · | |
| Other Non-current Liabilities | $36M | $36M | $38M | $38M | $44M | $52M | $54M | $54M | $59M | · | $65M | $63M | $66M | · | $58M | $51M | |
| Total Liabilities | $344M | $398M | $417M | $429M | $429M | $431M | $665M | $671M | $667M | · | $1.38B | $1.37B | $1.41B | · | $1.41B | $1.40B | |
| Long-term Debt | $241M | $292M | $293M | $294M | $295M | $296M | $522M | $523M | $523M | · | $525M | $526M | $527M | · | $528M | $529M | |
| Total Debt | $241M | · | $293M | $294M | $295M | · | $522M | $523M | $523M | · | $525M | $526M | $527M | · | $528M | $529M | |
| Paid-in Capital | $202M | $199M | $197M | $191M | $187M | $182M | $176M | $168M | $134M | · | $125M | $120M | $114M | · | $134M | $131M | |
| Retained Earnings | $6M | $10M | $46M | $71M | $111M | $141M | $167M | $266M | $274M | · | $392M | $398M | $405M | · | $367M | $323M | |
| AOCI | $466.0K | $524.0K | $579.0K | $574.0K | $324.0K | $0 | · | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $212M | $212M | $245M | $266M | $301M | $325M | $345M | $437M | $411M | · | $519M | $521M | $522M | · | $504M | $457M | |
| Liabilities + Equity | $713M | $771M | $849M | $897M | $960M | $1.01B | $1.28B | $1.45B | $1.44B | · | $2.27B | $2.26B | $2.32B | · | $2.25B | $2.17B |
Nakit Akışı 14
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $4M | $9M | $7M | $10M | $11M | $13M | $14M | $12M | $9M | $10M | $9M | $6M | $6M | $5M | $4M | |
| Deferred Tax | · | · | · | · | · | $11.0K | $0 | $0 | $0 | $765M | $-6M | $-3M | $-2M | $7M | $9M | $13M | |
| Amort. of Intangibles | $6M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | |
| Restructuring | $3M | $10M | $7M | $0 | $0 | $6.0K | $-4.0K | $-4.0K | $-1M | $6M | $0 | $0 | $0 | · | · | · | |
| Operating Cash Flow | $9M | $-23M | $-15M | $-10M | $-9M | $-15M | $13M | $17M | $-8M | $8M | $14M | $19M | $85M | $99M | $110M | $164M | |
| CapEx | $4M | $2M | $3M | $3M | $5M | $6M | $9M | $10M | $6M | $17M | $16M | $25M | $8M | $6M | $6M | $2M | |
| Investing Cash Flow | $-4M | $-2M | $-3M | $-3M | $-23M | $-5M | $-9M | $-6M | $-4M | $-13M | $-16M | $-24M | $-70M | $-19M | $-6M | $-2M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | $-51M | · | · | · | $-1M | · | · | · | $-1M | · | · | · | $-1M | · | · | · | |
| Financing Cash Flow | $-55M | $-2M | $-8M | $-2M | $-5M | $-236M | $809.0K | $228.0K | $-560.0K | $470.0K | $783.0K | $-43M | $-19M | $-66M | $-37M | $-43M | |
| Net Change in Cash | $-51M | $-27M | $-26M | $-15M | $-37M | $-256M | $5M | $11M | $-13M | $-5M | $-571.0K | $-48M | $-4M | $15M | $67M | $119M | |
| Taxes Paid | $0 | $6.0K | $-26.0K | $-674.0K | $139.0K | $26.0K | $267.0K | $180.0K | $197.0K | $90.0K | $-3M | $449.0K | $-521.0K | $3M | $6M | $13M | |
| Free Cash Flow | $4M | · | · | · | $-15M | · | · | · | $-14M | · | · | · | $77M | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | $-25M | · | · | · | $74M | · | · | · |
Kârlılık 8
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 51.2% | · | 13.6% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | -3.3% | · | -98.6% | -139.8% | -104.9% | · | -259.4% | -13.0% | -29.4% | · | -23.1% | -16.9% | 3.2% | · | 61.1% | 74.4% | |
| Net Margin | -5.7% | · | -61.4% | -83.5% | -63.9% | · | -151.9% | -10.3% | -18.8% | · | -9.7% | -9.5% | -0.08% | · | 23.2% | 29.3% | |
| Pretax Margin | -9.9% | · | -108.5% | -156.4% | -112.5% | · | -269.4% | -23.1% | -34.9% | · | -30.8% | -19.4% | -5.7% | · | 59.5% | 72.1% | |
| EBITDA Margin | -3.3% | · | -98.6% | -139.8% | -104.9% | · | -259.4% | -13.0% | -29.4% | · | -23.1% | -16.9% | 3.2% | · | 61.1% | 74.4% | |
| ROA | -0.45% | · | -2.4% | -3.4% | -2.5% | · | -5.6% | -0.41% | -0.64% | · | -0.29% | -0.29% | 0.00% | · | 2.1% | 3.8% | |
| ROE | -1.5% | · | -8.6% | -11.3% | -8.4% | · | -22.9% | -1.6% | -2.6% | · | -1.3% | -1.3% | -0.01% | · | 11.0% | 21.9% | |
| ROIC | -0.47% | · | -7.6% | -11.2% | -8.3% | · | -19.5% | -0.85% | -2.0% | · | -1.1% | -0.99% | 0.07% | · | 9.9% | 16.4% |
Likidite ve Solventlik 5
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.9 | · | 5.3 | 5.2 | 6.0 | · | 10.7 | 10.0 | 11.3 | · | 9.0 | 9.3 | 6.1 | · | 7.2 | 6.7 | |
| Quick Ratio | 4.7 | · | 4.3 | 4.3 | 5.0 | · | 9.6 | 8.9 | 10.1 | · | 8.0 | 8.4 | 5.5 | · | 6.3 | 6.0 | |
| Debt / Equity | 1.1 | · | 1.2 | 1.1 | 1.0 | · | 1.5 | 1.2 | 1.3 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.2 | |
| LT Debt / Equity | 1.1 | · | 1.2 | 1.1 | 1.0 | · | 1.5 | 1.2 | 1.3 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.1 | |
| Interest Coverage | · | · | · | · | · | · | -12.4 | -0.8 | -1.7 | · | -1.3 | -1.7 | 0.2 | · | 37.3 | 40.8 |
Verimlilik 3
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.1 | |
| Inventory Turnover | 0.7 | · | 0.8 | 0.8 | 0.8 | · | 0.7 | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | 0.7 | |
| Receivables Turnover | 2.1 | · | 1.6 | 1.4 | 1.4 | · | 1.7 | 1.7 | 1.4 | · | 0.8 | 0.8 | 0.9 | · | 2.1 | 2.4 |
Değerleme (TTM) 4
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $202M | · | $205M | $233M | $249M | · | $269M | $269M | $279M | · | $406M | $582M | $757M | · | $883M | $910M | |
| Net Income TTM | $-99M | · | $-192M | $-176M | $-149M | · | $-125M | $-35M | $-25M | · | $31M | $109M | $183M | · | $237M | $241M | |
| P/E | -4.2 | · | -2.1 | -2.0 | -2.1 | · | -9.3 | -27.5 | -45.6 | · | 41.7 | 15.2 | 10.2 | · | 14.1 | 14.9 | |
| Earnings Yield | -24.0% | · | -46.7% | -51.0% | -47.5% | · | -10.7% | -3.6% | -2.2% | · | 2.4% | 6.6% | 9.8% | · | 7.1% | 6.7% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2023-12-31 | |
|---|---|---|---|---|---|
| Gelir | $186M | $259M | — | — | $289M |
| Brüt Kâr Marjı % | 18.3% | — | — | — | — |
| Faaliyet Kâr Marjı % | -115.9% | -90.9% | — | — | -10.9% |
| Net Gelir | $-131M | $-145M | — | — | $-119M |
| Seyreltilmiş Hisse Başı Kâr | $-0.90 | $-1.05 | — | — | $-0.90 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2023-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 1.4 | 0.9 | — | — | 1.3 |
| Cari Oran | 6.6 | 7.5 | — | — | 8.0 |
| Cari Oran | 5.4 | 6.3 | — | — | 7.2 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2023-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-71M | $-22M | — | — | $61M |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.